Parathyroid Neoplasms
12
1
1
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
17%
2 trials in Phase 3/4
44%
4 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (12)
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
WHITE CAP: Intra-operative Parathyroid Tissue Sensor (PTS)-Guided Assessment of Parathyroid Viability and Surgical Decision-Making
The Registry of Oncology Outcomes Associated with Testing and Treatment
Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy
Lidocaine And Neuromonitoring in Thyroid Surgery
The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma
A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer
Using X-Ray Dye to Locate Hidden Parathyroid Tumors